Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Receives Consensus Recommendation of "Reduce" from Analysts

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Get Free Report) have been given a consensus rating of "Reduce" by the fourteen analysts that are currently covering the firm, MarketBeat reports. Four equities research analysts have rated the stock with a sell recommendation, eight have given a hold recommendation and two have given a buy recommendation to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $11.54.

Several analysts recently weighed in on the stock. Truist Financial reduced their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a report on Friday, January 31st. Bank of America raised their target price on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a report on Monday, January 13th. Wolfe Research raised shares of Walgreens Boots Alliance to a "hold" rating in a report on Monday, February 24th. Evercore ISI raised their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an "in-line" rating in a report on Monday, January 13th. Finally, Deutsche Bank Aktiengesellschaft cut shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and reduced their target price for the company from $11.00 to $9.00 in a report on Friday, February 28th.

Hedge Funds Weigh In On Walgreens Boots Alliance

A number of hedge funds have recently modified their holdings of the business. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of Walgreens Boots Alliance during the fourth quarter worth approximately $2,821,000. Yoffe Investment Management LLC purchased a new position in shares of Walgreens Boots Alliance during the fourth quarter worth approximately $102,000. LifeWealth Investments LLC purchased a new position in shares of Walgreens Boots Alliance during the fourth quarter worth approximately $97,000. Integrated Advisors Network LLC grew its position in shares of Walgreens Boots Alliance by 236.8% during the fourth quarter. Integrated Advisors Network LLC now owns 61,919 shares of the pharmacy operator's stock worth $578,000 after acquiring an additional 43,532 shares during the last quarter. Finally, WNY Asset Management LLC grew its position in Walgreens Boots Alliance by 0.9% in the 4th quarter. WNY Asset Management LLC now owns 161,227 shares of the pharmacy operator's stock valued at $1,504,000 after buying an additional 1,451 shares during the last quarter. 58.59% of the stock is currently owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Stock Down 0.6 %

Shares of WBA opened at $11.21 on Wednesday. The stock has a market capitalization of $9.69 billion, a PE ratio of -1.09, a P/E/G ratio of 1.31 and a beta of 0.62. Walgreens Boots Alliance has a 1 year low of $8.08 and a 1 year high of $22.05. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The company's 50-day simple moving average is $10.71 and its 200-day simple moving average is $9.73.

Remove Ads

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.13. The business had revenue of $39.50 billion for the quarter, compared to analysts' expectations of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business's quarterly revenue was up 7.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.66 earnings per share. Analysts forecast that Walgreens Boots Alliance will post 1.6 earnings per share for the current fiscal year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.